NASDAQ:ADMS - Adamas Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$8.01 +0.02 (+0.25 %)
(As of 03/20/2019 04:00 PM ET)
Previous Close$7.99
Today's Range$7.91 - $8.25
52-Week Range$7.42 - $32.90
Volume383,893 shs
Average Volume618,400 shs
Market Capitalization$219.87 million
P/E Ratio-1.64
Dividend YieldN/A

Analyst Ratings

Adamas Pharmaceuticals (NASDAQ:ADMS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
8 Wall Street analysts have issued ratings and price targets for Adamas Pharmaceuticals in the last 12 months. Their average twelve-month price target is $22.2857, suggesting that the stock has a possible upside of 178.22%. The high price target for ADMS is $40.00 and the low price target for ADMS is $5.00. There are currently 1 sell rating, 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldBuyBuyBuy
Consensus Rating Score: 2.382.782.783.00
Ratings Breakdown: 1 Sell Rating(s)
3 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $22.2857$30.7143$31.7143$47.75
Price Target Upside: 178.22% upside251.02% upside176.74% upside118.24% upside

Adamas Pharmaceuticals (NASDAQ:ADMS) Consensus Price Target History

Price Target History for Adamas Pharmaceuticals (NASDAQ:ADMS)

Adamas Pharmaceuticals (NASDAQ:ADMS) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/5/2019Piper Jaffray CompaniesSet Price TargetBuy$23.00HighView Rating Details
3/5/2019HC WainwrightSet Price TargetBuy$40.00HighView Rating Details
3/5/2019Northland SecuritiesReiterated RatingBuy$28.00LowView Rating Details
3/5/2019Needham & Company LLCDowngradeBuy ➝ HoldHighView Rating Details
3/5/2019CowenDowngradeOutperform ➝ Market Perform$30.00 ➝ $15.00HighView Rating Details
3/5/2019MizuhoDowngradeNeutral ➝ Underperform$11.00 ➝ $5.00HighView Rating Details
11/12/2018Leerink SwannInitiated CoverageOutperform$20.00LowView Rating Details
10/5/2018Bank of AmericaDowngradeBuy ➝ Neutral$36.00 ➝ $25.00HighView Rating Details
2/23/2018Noble FinancialReiterated RatingBuyLowView Rating Details
2/21/2018William BlairReiterated RatingOutperformLowView Rating Details
10/30/2017Evercore ISIInitiated CoverageOutperformN/AView Rating Details
8/25/2017JMP SecuritiesReiterated RatingMkt Outperform ➝ Outperform$29.00 ➝ $33.00HighView Rating Details
(Data available from 3/20/2017 forward)
This page was last updated on 3/20/2019 by Staff

Featured Article: What is a short straddle?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel